Life Science Intelligence (LSI) announced this month that another new
group of 23 mostly privately-held medtech companies has recently been
added to the EMT (Emerging Medical Technologies) Database.
According to LSI, this latest round of companies is collectively seeking
over $192M in financing as follows: $84.6M Series A, $43.5M Series B,
$31M Series C, $21.5M Series D, and $11.8M Undisclosed. Many of the
companies are also actively pursuing strategic partnerships and
licensing deals with large medtech companies.
LSI’s EMT Database provides medical technology
executives and venture capitalists with a searchable online resource
allowing them to discover, partner, and capitalize on opportunities in
emerging medtech start-up companies. Most of the companies in the
database include Executive Summaries and Presentations.
Start-ups in the EMT Database represent many market segments, including:
aesthetics, biomaterials, biotechnology, cardiovascular, cell therapy,
dental, dermatology, diagnostics, drug delivery, endocrine,
gastroenterology, gynecology, imaging, neurology, oncology,
ophthalmology, orthopedics, pain management, patient monitoring,
respiratory, spine, surgery, urology, vascular, and wound management.
More information on the EMT Database, along with the complete list of
emerging medical technologies (827 and growing), can be found at www.emergingmedicaltechnologies.com.
A free trial to the database is available at http://lifescienceintelligence.com/free-trial.php.
Firms and companies that have invested in or partnered with companies in
the EMT Database include: Accuitive Ventures, Advanced Technology
Ventures, Aesculap, Affinity Capital Partners, Alta Partners, Baird
Venture Partners, Battelle Ventures, Bay City Capital, Boston Scientific
(BSX), Canaan Ventures, Conmed (CNMD), Covidien (COV), CR Bard (BCR),
Delphi Ventures, Domain Associates, Edwards Lifesciences (EW), Essex
Woodlands, Frazier Healthcare Ventures, Galen Partners, Heidelberg
Innovation, JJDC, Johnson & Johnson (JNJ), JP Morgan, Medtronic (MDT),
Microsoft (MSFT), Morgenthaler Ventures, MPM Capital, NASA, Onset
Ventures, Oxford BioScience Partners, Path4 Ventures, Prism Venture
Partners, Rivervest Venture Partners, Sanderling Ventures, Sapient
Capital, Schroder Ventures, Sofinnova Ventures, Split Rock Partners, St.
Jude (STJ), Stryker (SYK), SV Life Sciences, Sycamore Ventures,
Trialthlon Medical Ventures, Versant Ventures, and Welch Allyn.
About Life Science Intelligence (LSI)
Life Science Intelligence (LSI) delivers high-quality market data and
information to medical technology executives, entrepreneurs, and
investors. LSI produces the EMT (Emerging Medical Technologies)
Database, medtech market reports, and provides custom research services,
including market assessments and physician surveys. In addition, LSI
partners with top-tier information companies such as Health Research
International (HRI) and Windhover/Medtech Insight to distribute their
high-end information products. www.LSintelligence.com.
|